Concord Health Partners (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:New York

Concord Health Partners is a venture capital investment firm that focuses on healthcare technologies.

Average round investment:105M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Switzerland MindMaze
Mostly invests in: Switzerland Switzerland (1) Biotech (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Concord Health Partners

Name Criteria
Germany Hitachi Ventures
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Foresite Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom AlbaCore Capital
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Gilde Healthcare
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland HBM Healthcare Investments
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Pfizer Venture Investments
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Luxembourg CVC Capital Partners
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Finland NGP Capital
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Hercules Capital
80%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Illumina Accelerator
80%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top